MedTrace Logo

A Study to Investigate the Effect of MCE on Glucose and Insulin Responses in Healthy Males

NCT04296045 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-10-19

No results posted yet for this study

Summary

Maize Cob Extract (MCE) is intended to be used as a bulking agent in food. The purpose of this study is to determine the glycaemic and insulinemic response of MCE consumed in isolation compared to glucose; the glycaemic and insulinemic response will also be determined for MCE alone and in combination with glucose. This is a randomised, double-blind, single-centre trial in 10 healthy male participants.

Conditions

  • Dysglycemia

Interventions

DIETARY_SUPPLEMENT

MCE

Ingestion of 15g MCE in water after min 10 hours of fasting

DIETARY_SUPPLEMENT

Glucose

Ingestion of 15g glucose in water after min 10 hours of fasting

Sponsors & Collaborators

  • Atlantia Food Clinical Trials

    collaborator INDUSTRY

  • Cambridge Glycoscience

    lead INDUSTRY

Principal Investigators

  • Thomas Nicholson, M.Phil; M.Sc · Cambridge Glycoscience

  • Timothy Dinan, M.D; Ph.D; D.Sc · Atlantia Food Clinical Trials

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-02
Primary Completion
2020-07-31
Completion
2020-08-28

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04296045 on ClinicalTrials.gov